DE69321332T2 - Hydroxyamin-N-acyl-Derivate mit Radikalfängeraktivität und nützlich in akuten und chronischen Erkrankungen die mit Peroxidations- und Entzündungserscheinungen einhergehen - Google Patents
Hydroxyamin-N-acyl-Derivate mit Radikalfängeraktivität und nützlich in akuten und chronischen Erkrankungen die mit Peroxidations- und Entzündungserscheinungen einhergehenInfo
- Publication number
- DE69321332T2 DE69321332T2 DE69321332T DE69321332T DE69321332T2 DE 69321332 T2 DE69321332 T2 DE 69321332T2 DE 69321332 T DE69321332 T DE 69321332T DE 69321332 T DE69321332 T DE 69321332T DE 69321332 T2 DE69321332 T2 DE 69321332T2
- Authority
- DE
- Germany
- Prior art keywords
- acyl derivatives
- hydroxyamine
- peroxidation
- acute
- useful
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000000694 effects Effects 0.000 title abstract 2
- 208000030090 Acute Disease Diseases 0.000 title 1
- 208000017667 Chronic Disease Diseases 0.000 title 1
- 206010061218 Inflammation Diseases 0.000 title 1
- 230000001154 acute effect Effects 0.000 title 1
- 230000004054 inflammatory process Effects 0.000 title 1
- 238000005502 peroxidation Methods 0.000 title 1
- 239000002516 radical scavenger Substances 0.000 title 1
- 208000024891 symptom Diseases 0.000 title 1
- IXNVNKMGHGWCFY-UHFFFAOYSA-N 3,4-dihydro-2h-benzo[h]chromene Chemical compound C1=CC2=CC=CC=C2C2=C1CCCO2 IXNVNKMGHGWCFY-UHFFFAOYSA-N 0.000 abstract 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical class ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- HBEDSQVIWPRPAY-UHFFFAOYSA-N dihydro-benzofuran Natural products C1=CC=C2OCCC2=C1 HBEDSQVIWPRPAY-UHFFFAOYSA-N 0.000 abstract 1
- 230000002526 effect on cardiovascular system Effects 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000002792 vascular Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/66—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
- C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Furan Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI922997A IT1256264B (it) | 1992-12-31 | 1992-12-31 | N-acilderivati di idrossiammine dotati di attivita' scavenger ed utilizzabili nelle patologie acute e croniche correlate a fenomeni di perossidazione ed infiammazione |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69321332D1 DE69321332D1 (de) | 1998-11-05 |
| DE69321332T2 true DE69321332T2 (de) | 1999-04-22 |
Family
ID=11364566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69321332T Expired - Fee Related DE69321332T2 (de) | 1992-12-31 | 1993-12-29 | Hydroxyamin-N-acyl-Derivate mit Radikalfängeraktivität und nützlich in akuten und chronischen Erkrankungen die mit Peroxidations- und Entzündungserscheinungen einhergehen |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5480645A (de) |
| EP (1) | EP0604995B1 (de) |
| JP (1) | JPH06234756A (de) |
| AT (1) | ATE171703T1 (de) |
| CA (1) | CA2112611A1 (de) |
| DE (1) | DE69321332T2 (de) |
| DK (1) | DK0604995T3 (de) |
| ES (1) | ES2124765T3 (de) |
| IT (1) | IT1256264B (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6017953A (en) * | 1993-12-28 | 2000-01-25 | Allergan Sales, Inc. | Thromboxane ligands |
| AU719146B2 (en) * | 1996-02-02 | 2000-05-04 | Merck & Co., Inc. | Antidiabetic agents |
| US5859051A (en) * | 1996-02-02 | 1999-01-12 | Merck & Co., Inc. | Antidiabetic agents |
| US6090839A (en) * | 1996-12-23 | 2000-07-18 | Merck & Co., Inc. | Antidiabetic agents |
| US6160000A (en) * | 1996-12-23 | 2000-12-12 | Merck & Co., Inc. | Antidiabetic agents based on aryl and heteroarylacetic acids |
| US6703384B2 (en) | 1998-09-23 | 2004-03-09 | Research Development Foundation | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| WO2000046183A1 (en) | 1999-02-08 | 2000-08-10 | Checkpoint Genetics, Inc. | N-substituted amino acids, antioxidant pharmaceutical compositions containing same and methods using same |
| CA2399802C (en) * | 2000-02-11 | 2009-12-08 | Research Development Foundation | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| US6299865B1 (en) * | 2000-05-02 | 2001-10-09 | Peter Styczynski | Reduction of hair growth |
| US6653346B1 (en) | 2002-02-07 | 2003-11-25 | Galileo Pharmaceuticals, Inc. | Cytoprotective benzofuran derivatives |
| US7078541B2 (en) * | 2002-02-07 | 2006-07-18 | Galileo Pharmaceuticals, Inc. | Benzofuran derivatives |
| CA2542795A1 (en) * | 2003-10-15 | 2005-04-28 | Matsushita Electric Industrial Co., Ltd. | Systems and methods for assessing neuronal degeneration |
| FR2875803B1 (fr) * | 2004-09-24 | 2006-11-24 | Catalys Sarl | Preparation de composes phenol-amides a proprietes antioxydantes |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5594382A (en) * | 1979-01-11 | 1980-07-17 | Eisai Co Ltd | Chroman-based compound and cholestrol lowering drug comprising it |
| CA2002649C (en) * | 1988-11-14 | 2000-06-06 | Margaret Petty | Cardioprotective tocopherol analogs |
| JPH02215778A (ja) * | 1989-02-14 | 1990-08-28 | Kuraray Co Ltd | ３，４―ジヒドロ―２ｈ―ベンゾピラン誘導体及びその医薬用途 |
| IT1231341B (it) * | 1989-08-18 | 1991-11-28 | Foscama Biomed Chim Farma | 2,3 diidro 5 ossi 4,6,7 trimetilbenzofurani 2 (rs) sostituiti, utili come farmaci antiossidanti con proprieta' mucoregolatrici e antiischemiche. |
| FR2676056B1 (fr) * | 1991-05-03 | 1993-07-16 | Adir | Nouveaux derives du benzopyranne leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| AU670433B2 (en) * | 1992-04-06 | 1996-07-18 | Merrell Dow Pharmaceuticals Inc. | Novel derivatives of 2,3-dihydro-benzofuranols |
-
1992
- 1992-12-31 IT ITMI922997A patent/IT1256264B/it active IP Right Grant
-
1993
- 1993-12-28 JP JP5350273A patent/JPH06234756A/ja active Pending
- 1993-12-29 EP EP93121046A patent/EP0604995B1/de not_active Expired - Lifetime
- 1993-12-29 US US08/175,233 patent/US5480645A/en not_active Expired - Fee Related
- 1993-12-29 DK DK93121046T patent/DK0604995T3/da active
- 1993-12-29 ES ES93121046T patent/ES2124765T3/es not_active Expired - Lifetime
- 1993-12-29 DE DE69321332T patent/DE69321332T2/de not_active Expired - Fee Related
- 1993-12-29 AT AT93121046T patent/ATE171703T1/de not_active IP Right Cessation
- 1993-12-30 CA CA002112611A patent/CA2112611A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US5480645A (en) | 1996-01-02 |
| EP0604995B1 (de) | 1998-09-30 |
| IT1256264B (it) | 1995-11-29 |
| ITMI922997A1 (it) | 1994-07-01 |
| DK0604995T3 (da) | 1999-06-21 |
| CA2112611A1 (en) | 1994-07-01 |
| EP0604995A1 (de) | 1994-07-06 |
| JPH06234756A (ja) | 1994-08-23 |
| ATE171703T1 (de) | 1998-10-15 |
| ITMI922997A0 (it) | 1992-12-31 |
| DE69321332D1 (de) | 1998-11-05 |
| ES2124765T3 (es) | 1999-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69321332T2 (de) | Hydroxyamin-N-acyl-Derivate mit Radikalfängeraktivität und nützlich in akuten und chronischen Erkrankungen die mit Peroxidations- und Entzündungserscheinungen einhergehen | |
| NZ331163A (en) | Composition comprising interleukin-1 inhibitor and hydrogel ester (hyaluronan) for treating inflammatory diseases | |
| ATE142877T1 (de) | Melatoninderivate zur behandlung von schlafstörungen und zur pre-anästhesie | |
| ATE215366T1 (de) | 3-benzoylphenylessigsäure-derivate enthaltende topische zusammensetzungen zur behandlung der ophthalmischen entzündungserkrankungen | |
| NO932983D0 (no) | Fettsyrebehandling | |
| NO930206L (no) | Farmasoeytiske blandinger | |
| ATE98125T1 (de) | Zusammensetzungen essentieller fettsaeuren und therapie. | |
| MC2078A1 (fr) | Emploi d'alezastine comme matiere active contre le psoriasis et des maladies inflammatoires | |
| DE68912195T2 (de) | Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis. | |
| DE3875286T2 (de) | Essentielle fettsaeure enthaltende zusammensetzungen. | |
| FI950909A (fi) | Rasvahappojohdannaisia | |
| ES2063060T3 (es) | Benzamida contra enfermedades cognoscitivas. | |
| FR2717080B1 (fr) | Utilisation de l'éliprodil et de ses énantiomères pour la préparation de médicaments utiles dans le traitement des neuropathies périphériques et des maladies neurodégénératives centrales. | |
| DE68911049D1 (de) | Therapeutische Verwendung des Isopropylesterderivates von Monosialogangliosiden bei Erkrankungen des Nervensystems, begleitet von Entzündungen. | |
| NO974551L (no) | Bruk av sulbutiamin for å fremskaffe farmasöytiske sammensetninger nyttige i behandling av visse psykomotoriske- og psyko-intellektuelle sykdommer | |
| FI944656A0 (fi) | Uudet kardioprotektiivset aineet | |
| DE3174977D1 (en) | Bioactive composition containing vegetable agents | |
| DE69201975T2 (de) | Pyrimido-benzothiazinderivate zur Behandlung von Entzündung, Allergie and kardiovaskulären Erkrankung. | |
| IT8019044A0 (it) | Derivati di acidi carbossilici conproprieta'terapeutiche per il trattamento di malattie coronariche, della arteriosclerosi e di forme infiammatorie |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |